NAMSW
NewAmsterdam Pharma Company N.V.
NASDAQ · Healthcare · Biotechnology · NL
$13.88
−3.88%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 57.91x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.51x
- Price / sales
- 222.98x
- Price / cash flow
- -11.07x
Enterprise value
- Enterprise value
- $954.1M
- EV / sales
- 133.98x
- EV / EBITDA
- -3.74x
- EV / EBIT
- -3.90x
- Market cap
- $1.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026